Hambrecht & Quist Capital Management LLC
Latest statistics and disclosures from Tekla Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are GILD, CELG, BIIB, VRTX, AMGN, and represent 27.14% of Tekla Capital Management's stock portfolio.
- Added to shares of these 10 stocks: AMGN (+$59.59M), JNJ (+$33.77M), Mylan Nv (+$16.18M), MCK (+$14.54M), TMO (+$13.35M), XLV (+$10.46M), BMY (+$10.14M), UNH (+$9.99M), ILMN (+$8.67M), Tetraphase Pharmaceuticals (+$7.46M).
- Started 8 new stock positions in Flamel Technologies Sa, DXCM, XLV, NVO, BMY, Innoviva, Nanostring Technologies, EW.
- Reduced shares in these 10 stocks: Allergan (-$29.50M), MDCO (-$26.19M), INCY (-$25.02M), ABT (-$19.15M), CNC (-$18.22M), BIIB (-$14.32M), UHS (-$12.27M), HCA HOLDINGS Inc (-$11.28M), BDX (-$10.44M), Global Blood Therapeutics In (-$7.69M).
- Sold out of its positions in ACAD, ACHN, Adamas Pharmaceuticals, BDX, Chimerix, ELGX, Esperion Therapeutics, FLML, Immunomedics Inc note 4.750% 2/1, MDCO. Therapeuticsmd, Icon.
- Tekla Capital Management was a net buyer of stock by $10.74M.
- Tekla Capital Management has $2.58B in assets under management (AUM), growing by 9.87%.
Tekla Capital Management portfolio companies for March 2017 quarter
| Company (Ticker) | Portfolio Weight | Share Count | Price | Last Trade |
|---|---|---|---|---|
| Gilead Sciences (GILD) | 6.66 | 2.53M | 67.92 | 74.19 |
| Celgene Corporation (CELG) | 6.59 | 1.37M -3.00% | 124.43 | 137.75 |
| Biogen Idec (BIIB) | 5.14 | 484974 -9.00% | 273.42 | 295.61 |
| Vertex Pharmaceuticals Incorporated (VRTX) | 4.38 | 1.03M | 109.35 | 163.42 |
| Amgen (AMGN) | 4.36 | 684824 +112.00% | 164.07 | 175.89 |
| Alexion Pharmaceuticals (ALXN) | 3.74 | 795905 | 121.24 | 131.07 |
| Incyte Corporation (INCY) | 3.59 | 693275 -21.00% | 133.67 | 137.19 |
| Johnson & Johnson (JNJ) | 3.45 | 714362 +61.00% | 124.55 | 130.95 |
| Merck & Co (MRK) | 2.95 | 1.20M | 63.54 | 61.80 |
| Allergan | 2.88 | 310610 -28.00% | 238.92 | 0.00 |
| Regeneron Pharmaceuticals (REGN) | 2.82 | 187666 | 387.51 | 515.63 |
| Mylan Nv | 2.34 | 1.55M +36.00% | 38.99 | 0.00 |
| Abbott Laboratories (ABT) | 1.98 | 1.15M -27.00% | 44.41 | 50.40 |
| Illumina (ILMN) | 1.97 | 297360 +20.00% | 170.64 | 176.30 |
| UnitedHealth (UNH) | 1.95 | 306852 +24.00% | 164.01 | 190.75 |
| Medtronic | 1.91 | 613030 | 80.56 | 0.00 |
| Jazz Pharmaceuticals | 1.86 | 331411 | 145.13 | 0.00 |
| BioMarin Pharmaceutical (BMRN) | 1.72 | 505845 -11.00% | 87.78 | 89.20 |
| Eli Lilly & Co. (LLY) | 1.61 | 493100 | 84.11 | 81.84 |
| Shire (SHPGY) | 1.56 | 231413 | 174.23 | 0.00 |
| Pfizer (PFE) | 1.52 | 1.15M | 34.21 | 32.89 |
| Thermo Fisher Scientific (TMO) | 1.36 | 228020 +61.00% | 153.60 | 175.06 |
| Teva Pharmaceutical Industries (TEVA) | 1.26 | 1.02M +28.00% | 32.09 | 33.04 |
| CVS Caremark Corporation (CVS) | 1.25 | 411891 | 78.50 | 78.29 |
| Humana (HUM) | 1.23 | 153800 -6.00% | 206.14 | 233.50 |
| AmerisourceBergen (ABC) | 1.13 | 330687 | 88.50 | 94.21 |
| iShares NASDAQ Biotechnology Index (IBB) | 0.89 | 77970 +35.00% | 293.27 | 325.90 |
| IDEXX Laboratories (IDXX) | 0.79 | 132352 | 154.61 | 166.83 |
| Neurocrine Biosciences (NBIX) | 0.75 | 446074 +13.00% | 43.30 | 49.00 |
| Novartis AG (NVS) | 0.72 | 248800 | 74.27 | 84.85 |
| Molina Healthcare (MOH) | 0.71 | 402541 | 45.60 | 69.71 |
| McKesson Corporation (MCK) | 0.65 | 113100 +654.00% | 148.26 | 166.35 |
| SPDR S&P; Biotech (XBI) | 0.61 | 226460 +26.00% | 69.34 | 80.79 |
| Sabra Health Care REIT (SBRA) | 0.60 | 550990 | 27.93 | 23.57 |
| GlaxoSmithKline (GSK) | 0.59 | 359000 | 42.16 | 40.85 |
| Omega Healthcare Investors (OHI) | 0.59 | 458616 | 32.99 | 33.45 |
| Sarepta Therapeutics | 0.59 | 511600 +9.00% | 29.60 | 0.00 |
| Paratek Pharmaceuticals | 0.57 | 762581 | 19.25 | 0.00 |
| AstraZeneca (AZN) | 0.56 | 463800 | 31.14 | 33.94 |
| Sanofi-Aventis SA (SNY) | 0.54 | 305000 | 45.25 | 48.02 |
| Senior Housing Properties Trust (SNH) | 0.51 | 646554 | 20.25 | 19.37 |
| Medical Properties Trust (MPW) | 0.50 | 1.01M | 12.89 | 13.00 |
| Welltower Inc 6.50% pfd prepet | 0.49 | 200000 | 63.12 | 0.00 |
| CIGNA Corporation (CI) | 0.48 | 83900 -2.00% | 146.50 | 173.57 |
| Zimmer Holdings (ZMH) | 0.48 | 102300 | 122.11 | 113.56 |
| Alnylam Pharmaceuticals (ALNY) | 0.48 | 243995 | 51.25 | 81.57 |
| Exelixis (EXEL) | 0.46 | 551647 | 21.67 | 28.02 |
| Merus N V | 0.45 | 479150 | 24.38 | 0.00 |
| Charles River Laboratories (CRL) | 0.44 | 127100 | 89.95 | 99.44 |
| Ventas (VTR) | 0.44 | 175991 | 65.04 | 68.08 |
| Health Care SPDR (XLV) | 0.41 | 140600 NEW | 74.36 | 80.11 |
| Physicians Realty Trust | 0.41 | 530672 | 19.87 | 0.00 |
| Centene Corporation (CNC) | 0.40 | 144300 -63.00% | 71.26 | 83.39 |
| Endo International | 0.40 | 914548 | 11.16 | 0.00 |
| Pieris Pharmaceuticals | 0.40 | 3.94M -4.00% | 2.60 | 0.00 |
| Aegerion Pharmaceuticals 2% Du cvbond | 0.40 | 13.00M | 0.80 | 0.00 |
| Bristol Myers Squibb (BMY) | 0.39 | 186500 NEW | 54.38 | 55.98 |
| Acadia Healthcare | 0.39 | 231200 +256.00% | 43.60 | 0.00 |
| Galapagos Nv-spon | 0.39 | 115738 | 86.19 | 0.00 |
| Puma Biotechnology Inc Common Stock | 0.38 | 260200 | 37.20 | 0.00 |
| Tetraphase Pharmaceuticals | 0.36 | 1.00M +422.00% | 9.19 | 0.00 |
| Care Cap Properties | 0.36 | 345022 | 26.87 | 0.00 |
| Cytomx Therapeutics | 0.35 | 530092 -29.00% | 17.27 | 0.00 |
| Akorn (AKRX) | 0.31 | 327735 | 24.08 | 33.63 |
| Ardelyx | 0.31 | 639370 | 12.65 | 0.00 |
| Adaptimmune Therapeutics | 0.31 | 1.47M +158.00% | 5.51 | 0.00 |
| Karyopharm Therapeutics | 0.30 | 605224 +20.00% | 12.84 | 0.00 |
| Natera | 0.30 | 882358 | 8.87 | 0.00 |
| Cellectis S A sponsored ads | 0.29 | 310250 | 24.00 | 0.00 |
| Momenta Pharmaceuticals (MNTA) | 0.26 | 504400 +64.00% | 13.35 | 16.75 |
| Pra Health Sciences | 0.26 | 102000 | 65.23 | 0.00 |
| LTC Properties (LTC) | 0.25 | 136212 | 47.90 | 51.67 |
| Sage Therapeutics | 0.25 | 90480 +67.00% | 71.07 | 0.00 |
| Global Blood Therapeutics In | 0.25 | 172500 -54.00% | 36.85 | 0.00 |
| Cardinal Health (CAH) | 0.24 | 76600 -49.00% | 81.55 | 77.67 |
| Epizyme | 0.24 | 362000 -9.00% | 17.15 | 0.00 |
| Universal Health Services (UHS) | 0.23 | 48180 -67.00% | 124.45 | 112.88 |
| United Therapeutics Corporation (UTHR) | 0.23 | 43961 -52.00% | 135.37 | 131.40 |
| Dex (DXCM) | 0.23 | 71200 NEW | 84.73 | 68.75 |
| Ultragenyx Pharmaceutical | 0.23 | 88400 | 67.78 | 0.00 |
| Flamel Technologies Sa | 0.23 | 624288 NEW | 9.68 | 0.00 |
| HCA HOLDINGS Inc | 0.22 | 63432 -66.00% | 88.99 | 0.00 |
| New Senior Inv Grp | 0.22 | 567997 | 10.20 | 0.00 |
| Dermira | 0.22 | 165200 | 34.11 | 0.00 |
| Egalet Corporation note 5.50% 4/1/20 | 0.22 | 7.00M | 0.82 | 0.00 |
| Edwards Lifesciences (EW) | 0.20 | 55900 NEW | 94.08 | 115.61 |
| Foamix Pharmaceuticals Ltd shs | 0.18 | 930398 | 4.95 | 0.00 |
| Myovant Sciences | 0.18 | 400000 | 11.74 | 0.00 |
| Bluebird Bio | 0.17 | 49345 | 90.89 | 0.00 |
| Allergan Plc pfd conv ser a | 0.16 | 5000 | 849.80 | 0.00 |
| Affimed Therapeutics B V | 0.13 | 1.41M +377.00% | 2.30 | 0.00 |
| Innoviva | 0.13 | 248803 NEW | 13.83 | 0.00 |
| Amicus Therapeutics (FOLD) | 0.12 | 418730 | 7.13 | 13.70 |
| Grifols S A Sponsored Adr R | 0.12 | 166000 | 18.87 | 0.00 |
| Retrophin | 0.12 | 167949 | 18.46 | 0.00 |
| Beigene | 0.12 | 87531 -24.00% | 36.62 | 0.00 |
| Novo Nordisk A/S (NVO) | 0.11 | 83000 NEW | 34.28 | 41.99 |
| Tenet Healthcare Corporation stock | 0.11 | 164500 | 17.71 | 0.00 |
| Mallinckrodt Pub | 0.11 | 61900 | 44.57 | 0.00 |
| Nabriva Therapeutics Ag | 0.11 | 233334 -33.00% | 11.99 | 0.00 |
| Halozyme Therapeutics (HALO) | 0.10 | 200000 | 12.96 | 13.53 |
| Perrigo Company | 0.10 | 37300 | 66.38 | 0.00 |
| Forward Pharma A/s | 0.10 | 122835 -10.00% | 21.51 | 0.00 |
| Healthcare Realty Trust Incorporated (HR) | 0.09 | 68000 | 32.50 | 33.41 |
| Accelr8 Technology | 0.09 | 100000 -16.00% | 24.20 | 0.00 |
| Nanostring Technologies | 0.09 | 113500 NEW | 19.87 | 0.00 |
| Horizon Pharma | 0.09 | 162900 | 14.78 | 0.00 |
| Dbv Technologies S A | 0.09 | 65600 | 35.21 | 0.00 |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.09 | 286472 +116.00% | 7.80 | 0.00 |
| Valeant Pharmaceuticals Int (VRX) | 0.08 | 192000 | 11.03 | 17.77 |
| Dynavax Technologies | 0.08 | 345050 | 5.95 | 0.00 |
| Diplomat Pharmacy | 0.08 | 130223 | 15.95 | 0.00 |
| Arca Biopharma | 0.08 | 811227 | 2.50 | 0.00 |
| Community Health Systems (CYH) | 0.07 | 203935 | 8.87 | 8.46 |
| Coherus Biosciences | 0.07 | 90000 | 21.16 | 0.00 |
| Impax Laboratories (IPXL) | 0.06 | 124335 | 12.65 | 19.75 |
| HCP (HCP) | 0.06 | 45500 | 31.27 | 31.99 |
| Acceleron Pharma | 0.06 | 54450 | 26.46 | 0.00 |
| Healthcare Tr Amer Inc cl a | 0.06 | 46000 | 31.46 | 0.00 |
| Welltower Inc Com reit | 0.06 | 21400 | 70.84 | 0.00 |
| GenMark Diagnostics (GNMK) | 0.05 | 93349 | 12.82 | 12.51 |
| Uniqure Nv shs | 0.05 | 241021 | 5.78 | 0.00 |
| Juno Therapeutics | 0.05 | 56900 | 22.20 | 0.00 |
| Xenon Pharmaceuticals | 0.05 | 350000 -50.00% | 4.00 | 0.00 |
| Spark Therapeutics | 0.05 | 24300 | 53.33 | 0.00 |
| Intellia Therapeutics Inc Com stock | 0.04 | 71842 | 14.09 | 0.00 |
| Novavax (NVAX) | 0.03 | 571000 | 1.28 | 1.09 |
| Alliqua | 0.03 | 1.65M | 0.50 | 0.00 |
| Auris Med Hldg Ag | 0.03 | 774504 | 0.92 | 0.00 |
| Bellicum Pharma | 0.03 | 60000 | 12.33 | 0.00 |
| Flex Pharma | 0.03 | 162124 | 4.40 | 0.00 |
| Global Medical Reit, Inc. stock | 0.03 | 73400 | 9.07 | 0.00 |
| Allscripts Healthcare Solutions (MDRX) | 0.02 | 47300 -72.00% | 12.68 | 12.51 |
| Xencor | 0.02 | 20000 | 23.90 | 0.00 |
| Celldex Therapeutics (CLDX) | 0.01 | 105800 | 3.61 | 2.38 |
| Rmr Group Inc cl a | 0.01 | 7441 | 49.46 | 0.00 |
| Quorum Health | 0.01 | 23725 | 5.44 | 0.00 |
| Abbvie | 0.00 | 156 | 64.10 | 0.00 |
| Zafgen | 0.00 | 13307 | 4.66 | 0.00 |
Download CSV 
Past 13F-HR SEC Filings for Tekla Capital Management
- Tekla Capital Management 2016 Q4 filed Feb. 13, 2017
- Tekla Capital Management 2016 Q3 filed Nov. 14, 2016
- Tekla Capital Management 2016 Q2 filed Aug. 12, 2016
- Tekla Capital Management 2016 Q1 filed May 9, 2016
- Tekla Capital Management 2015 Q4 filed Feb. 9, 2016
- Tekla Capital Management 2015 Q3 filed Nov. 13, 2015
- Tekla Capital Management 2015 Q2 filed Aug. 12, 2015
- Tekla Capital Management 2015 Q1 filed May 6, 2015
- Tekla Capital Management 2014 Q4 filed Jan. 30, 2015
- Tekla Capital Management 2014 Q2 filed Aug. 5, 2014
- Tekla Capital Management 2014 Q1 filed May 13, 2014
- Tekla Capital Management 2013 Q4 filed Jan. 28, 2014
- Tekla Capital Management 2013 Q3 filed Oct. 30, 2013
- Tekla Capital Management 2013 Q2 filed July 31, 2013
- Tekla Capital Management 2013 Q1 filed April 26, 2013
- Tekla Capital Management 2012 Q4 filed Feb. 1, 2013
- Tekla Capital Management 2012 Q3 filed Oct. 19, 2012
- Tekla Capital Management 2012 Q2 filed July 31, 2012
- Hambrecht & Quist Capital Management 2012 Q1 filed May 8, 2012